Getinge funds increased ventilator production through new CP programme
Swedish biotech company Getinge raised Skr1bn ($100m) of commercial paper off a new Covid-19 Financing Framework on Friday to it help meet increased demand for ventilators as a result of the coronavirus pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts